Allergan, an AbbVie Company, Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia Biotech Investing
HUMIRA® Receives FDA Approval to Treat Pediatric Patients Living with Moderately to Severely Active Ulcerative Colitis Biotech Investing
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights Biotech Investing
AbbVie's SKYRIZI® for the Treatment of Moderate to Severe Plaque Psoriasis now Publicly Reimbursed across Canada Biotech Investing
Bristol Myers Squibb to Take Part in the Cowen Virtual 41st Annual Health Care Conference Biotech Investing
Beyond Medical Provides Update on Made in Canada Medical Face Masks and Start of Manufacturing of N95 Face Masks Biotech Investing
